Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

June 16, 2021

Mallinckrodt obtains FDA approval for StrataGraft to treat thermal burns

Mallinckrodt has received the US Food and Drug Administration (FDA) approval for StrataGraft to treat thermal burns with intact dermal elements in adults.

Mallinckrodt obtains FDA approval for StrataGraft to treat thermal burns